... Note that rosiglitazone (Avandia) is rarely used due to cardiovascular risk concerns. Dipeptidyl peptidase 4 (DPP4) inhibitors — These drugs help the body continue to make insulin. DPP4 inhibitors include alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia and Zituvio). ...
    
   
  
    Type 2 Diabetes Treatment and Research
    
      ... Note that rosiglitazone (Avandia) is rarely used due to cardiovascular risk concerns. Dipeptidyl peptidase 4 (DPP4) inhibitors — These drugs help the body continue to make insulin. DPP4 inhibitors include alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia and Zituvio). ...